A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

CABA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.33%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,498,860.00

Cabaletta Bio Insider Trading History Chart

Cabaletta Bio Share Price & Price History

^$13.32

▼ -0.02 (-0.15%)

As of 04/22/2024 01:00 AM ET

Days: 30 | 90 | 365

Claim Your Complimentary Bitcoin Reward

From Crypto Swap Profits | Ad

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now

Cabaletta Bio Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/19/2024	Gwendolyn Binder	Insider	Sell	11,000	$19.59	$215,490.00	20,000
12/19/2023	Gwendolyn Binder	Insider	Sell	11,000	$21.89	$240,790.00	20,000
10/19/2023	Gwendolyn Binder	Insider	Sell	11,000	$13.36	$146,960.00	20,000
9/19/2023	Gwendolyn Binder	Insider	Sell	11,000	$17.57	$193,270.00	20,000
8/21/2023	Gwendolyn Binder	Insider	Sell	11,000	$13.42	$147,620.00	20,000
7/19/2023	Gwendolyn Binder	Insider	Sell	11,000	$13.82	$152,020.00	20,000
6/20/2023	Gwendolyn Binder	Insider	Sell	11,000	$12.99	$142,890.00	20,000
5/19/2023	Gwendolyn Binder	Insider	Sell	22,000	$11.81	$259,820.00	20,000
10/18/2022	Anup Marda	CFO	Buy	50,000	$0.99	$49,500.00	50,000
10/18/2022	Catherine Bollard	Director	Buy	1,000	$0.99	$990.00	1,000
10/18/2022	Gwendolyn Binder	Insider	Buy	20,000	$0.99	$19,800.00	20,000
10/18/2022	Steven Nichtberger	CEO	Buy	141,873	$0.99	$140,454.27	978,356
11/1/2021	Ventures V L.P. 5Am	Major Shareholder	Sell	295,000	$13.00	$3,835,000.00
9/7/2021	Ventures V L.P. 5Am	Major Shareholder	Sell	625,000	$9.70	$6,062,500.00

The "Smart Money" Is Ready for May 1st Are You?

From Stansberry Research | Ad

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

One Former Wall St. Trader Explains Why…

SEC Filings (Institutional Ownership Changes) for Cabaletta Bio (NASDAQ:CABA)

Institutional Buying and Selling by Quarter

Cabaletta Bio Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/11/2024	CHURCHILL MANAGEMENT Corp	46,606	$0.80M	0.0%	-5.6%	0.097%
3/5/2024	Wellington Management Group LLP	539,876	$12.26M	0.0%	+119.0%	1.260%
2/26/2024	Perceptive Advisors LLC	2,003,058	$45.47M	1.0%	+76.9%	4.675%
2/15/2024	Birchview Capital LP	10,000	$0.23M	0.2%	N/A	0.023%
2/15/2024	Blackstone Inc.	347,494	$7.89M	0.0%	N/A	0.811%
2/14/2024	Commodore Capital LP	1,900,000	$43.13M	3.8%	-24.8%	4.434%
2/13/2024	Tower Research Capital LLC TRC	2,623	$60K	0.0%	+65.9%	0.006%
2/13/2024	Rafferty Asset Management LLC	209,263	$4.75M	0.0%	+77.1%	0.488%
2/12/2024	TD Asset Management Inc	93,630	$2.13M	0.0%	N/A	0.219%
2/8/2024	Nicholas Investment Partners LP	54,586	$1.24M	0.1%	N/A	0.127%
2/8/2024	First Turn Management LLC	175,359	$3.98M	0.6%	N/A	0.409%
2/7/2024	E Fund Management Co. Ltd.	11,239	$0.26M	0.0%	N/A	0.026%
2/6/2024	Swiss National Bank	51,000	$1.16M	0.0%	-16.5%	0.119%
2/5/2024	Victory Capital Management Inc.	403,927	$9.17M	0.0%	+506.0%	0.943%
2/1/2024	New York State Common Retirement Fund	25,191	$0.57M	0.0%	+143.1%	0.059%
2/1/2024	Jennison Associates LLC	1,626,628	$36.92M	0.0%	+14.4%	3.796%
1/30/2024	HealthInvest Partners AB	21,000	$0.48M	0.4%	N/A	0.049%
1/30/2024	Macroview Investment Management LLC	1,131	$26K	0.0%	N/A	0.003%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	4,739	$0.11M	0.0%	-37.1%	0.011%
1/25/2024	Allspring Global Investments Holdings LLC	1,164	$26K	0.0%	-71.9%	0.003%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	23,689	$0.54M	0.0%	+41.0%	0.055%
1/24/2024	China Universal Asset Management Co. Ltd.	4,962	$0.11M	0.0%	N/A	0.012%
1/19/2024	Denali Advisors LLC	17,300	$0.39M	0.1%	N/A	0.040%
1/16/2024	CHURCHILL MANAGEMENT Corp	49,356	$1.12M	0.0%	-13.5%	0.115%
1/12/2024	SG Americas Securities LLC	9,740	$0.22M	0.0%	N/A	0.023%
12/18/2023	Vanguard Group Inc.	1,968,108	$29.96M	0.0%	+14.3%	4.593%
12/6/2023	Citigroup Inc.	49,695	$0.76M	0.0%	+552.4%	0.116%
12/1/2023	Wellington Management Group LLP	246,570	$3.75M	0.0%	N/A	0.575%
11/15/2023	Redmile Group LLC	1,774,252	$27M	1.3%	+29.5%	4.141%
11/14/2023	Fred Alger Management LLC	4,259,455	$64.83M	0.4%	-6.9%	9.941%
11/14/2023	Lynx1 Capital Management LP	2,106,000	$32.05M	21.2%	-3.5%	4.915%
11/14/2023	Nan Fung Group Holdings Ltd	47,150	$0.72M	0.6%	+14.7%	0.110%
11/14/2023	Profund Advisors LLC	20,121	$0.31M	0.0%	N/A	0.047%
11/13/2023	EAM Investors LLC	55,156	$0.84M	0.2%	N/A	0.129%
11/13/2023	Invesco Ltd.	854,043	$13M	0.0%	-0.3%	1.993%
11/13/2023	Rafferty Asset Management LLC	118,150	$1.80M	0.0%	N/A	0.276%
11/9/2023	Citigroup Inc.	49,695	$0.76M	0.0%	+552.4%	0.125%
11/8/2023	Swiss National Bank	61,100	$0.93M	0.0%	N/A	0.153%
11/8/2023	Amalgamated Bank	4,648	$71K	0.0%	+24.7%	0.012%
11/8/2023	J.P. Morgan Private Wealth Advisors LLC	18,542	$0.28M	0.0%	-20.9%	0.047%
11/7/2023	Barclays PLC	64,586	$0.98M	0.0%	+1,167.4%	0.162%
11/6/2023	Victory Capital Management Inc.	66,650	$1.01M	0.0%	+11.7%	0.167%
10/31/2023	Jennison Associates LLC	1,422,367	$21.65M	0.0%	+20.5%	3.573%
10/27/2023	Allspring Global Investments Holdings LLC	4,136	$63K	0.0%	N/A	0.010%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	16,798	$0.26M	0.0%	+29.2%	0.042%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	7,539	$0.12M	0.0%	N/A	0.019%
10/24/2023	Bank of New York Mellon Corp	145,467	$2.21M	0.0%	+16.1%	0.365%
10/12/2023	CHURCHILL MANAGEMENT Corp	57,047	$0.87M	0.0%	N/A	0.143%
9/21/2023	Barclays PLC	5,096	$65K	0.0%	-92.4%	0.013%
8/24/2023	Perceptive Advisors LLC	1,545,000	$19.95M	0.6%	+113.2%	3.881%
8/21/2023	Affinity Asset Advisors LLC	125,000	$1.61M	0.6%	N/A	0.314%
8/15/2023	Bain Capital Life Sciences Investors LLC	2,000,000	$25.82M	2.7%	N/A	5.024%
8/15/2023	Commodore Capital LP	2,368,186	$30.57M	3.4%	+29.1%	5.949%
8/14/2023	Cormorant Asset Management LP	2,221,739	$28.68M	1.6%	+22.0%	7.086%
8/11/2023	Nan Fung Group Holdings Ltd	41,123	$0.53M	0.3%	N/A	0.131%
8/4/2023	American International Group Inc.	12,311	$0.16M	0.0%	N/A	0.039%
8/3/2023	Jennison Associates LLC	1,180,564	$15.24M	0.0%	+51.2%	3.765%
8/3/2023	Bank of New York Mellon Corp	125,296	$1.62M	0.0%	+386.8%	0.400%
7/31/2023	LPL Financial LLC	31,603	$0.41M	0.0%	+27.5%	0.101%
7/28/2023	First Republic Investment Management Inc.	23,455	$0.30M	0.0%	-29.1%	0.075%
7/27/2023	Victory Capital Management Inc.	59,670	$0.77M	0.0%	N/A	0.190%
5/15/2023	Commodore Capital LP	1,835,000	$15.18M	2.3%	+81.6%	6.225%
5/9/2023	Concorde Asset Management LLC	15,800	$0.13M	0.2%	N/A	0.054%
5/4/2023	Barclays PLC	67,198	$0.56M	0.0%	+1,520.8%	0.228%
4/26/2023	Jennison Associates LLC	780,564	$6.46M	0.0%	N/A	2.648%
2/15/2023	Eversept Partners LP	282,874	$2.62M	0.2%	-49.5%	0.975%
2/15/2023	Boone Capital Management LLC	266,882	$2.47M	1.3%	N/A	0.920%
2/15/2023	Freedom Wealth Alliance LLC	4,416	$41K	0.1%	N/A	0.015%
2/14/2023	VR Adviser LLC	1,895,285	$17.53M	2.8%	N/A	6.533%
2/14/2023	683 Capital Management LLC	26,963	$0.25M	0.0%	N/A	0.093%
1/12/2023	Marquette Asset Management LLC	13,539	$0.13M	0.0%	N/A	0.047%
11/15/2022	Kynam Capital Management LP	527,805	$0.34M	0.1%	-3.5%	1.819%
11/1/2022	Privium Fund Management UK Ltd	331,218	$0.22M	0.3%	N/A	1.142%
10/28/2022	Harbor Capital Advisors Inc.	143,629	$93K	0.1%	+27.1%	0.495%
8/15/2022	Samlyn Capital LLC	1,919,907	$2.04M	0.0%	+8.6%	6.626%
8/12/2022	Ikarian Capital LLC	944,431	$1M	0.2%	-35.7%	3.259%
8/12/2022	DLD Asset Management LP	246,500	$0.26M	0.0%	N/A	0.851%
5/13/2022	Kynam Capital Management LP	616,125	$1.25M	0.4%	-4.4%	2.458%
5/12/2022	CI Investments Inc.	129,010	$0.26M	0.0%	N/A	0.515%
5/11/2022	Veritable L.P.	37,245	$76K	0.0%	+254.7%	0.149%
5/9/2022	Powell Investment Advisors LLC	15,000	$30K	0.0%	N/A	0.060%
5/4/2022	Victory Capital Management Inc.	42,659	$59K	0.0%	-83.9%	0.170%
4/28/2022	Harbor Capital Advisors Inc.	119,315	$0.24M	0.1%	-16.4%	0.476%
2/16/2022	Ghost Tree Capital LLC	135,000	$0.51M	0.2%	+35.0%	0.476%
2/15/2022	Samlyn Capital LLC	1,383,381	$5.24M	0.1%	+295.8%	4.883%
2/15/2022	683 Capital Management LLC	36,118	$0.14M	0.0%	N/A	0.127%
2/15/2022	Adage Capital Partners GP L.L.C.	2,541,645	$9.63M	0.0%	-16.4%	8.971%
2/14/2022	Boxer Capital LLC	540,000	$2.05M	0.1%	-66.3%	1.906%
2/14/2022	Point72 Asset Management L.P.	950,000	$3.60M	0.0%	+5.6%	3.353%
2/10/2022	Qube Research & Technologies Ltd	14,497	$55K	0.0%	N/A	0.051%
2/7/2022	Victory Capital Management Inc.	264,224	$1M	0.0%	+20.2%	0.933%
2/7/2022	SG Americas Securities LLC	11,186	$42K	0.0%	N/A	0.039%
2/4/2022	Harbor Capital Advisors Inc.	142,787	$0.54M	0.2%	N/A	0.504%
2/3/2022	5AM Venture Management LLC	2,064,263	$7.82M	1.5%	-12.5%	7.286%
2/1/2022	Qube Research & Technologies Ltd	14,497	$55K	0.0%	N/A	0.051%
1/28/2022	Allspring Global Investments Holdings LLC	21,650	$82K	0.0%	N/A	0.076%
11/16/2021	Two Sigma Advisers LP	40,100	$0.49M	0.0%	+226.0%	0.142%
11/16/2021	Two Sigma Investments LP	79,330	$0.97M	0.0%	+524.3%	0.280%
11/15/2021	Point72 Asset Management L.P.	900,000	$10.94M	0.0%	N/A	3.177%
11/15/2021	Marshall Wace LLP	64,155	$0.78M	0.0%	N/A	0.226%

Data available starting January 2016

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company's lead product candidate is CABA-201, a fully human anti-CD19 binder for the treatment of Phase 1/2 clinical trials in dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, lupus nephritis, non-renal systemic lupus erythematosus, systemic sclerosis, and generalized myasthenia gravis. It also develops DSG3-CAART, which is in Phase I/II clinical trial for the treatment of mucosal pemphigus vulgaris; and MuSK-CAART, an investigational cell therapy that is in Phase I/II clinical trial for treating patients with anti- muscle-specific kinase antibody positive myasthenia gravis. It has a collaboration with the University of Pennsylvania and the Children's Hospital of Philadelphia; Nanjing IASO Biotherapeutics Co., Ltd; Oxford Biomedica; and WuXi Advanced Therapies, Inc. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.

Today's Range

Now: $13.32

$12.88

$13.59

50 Day Range

MA: $19.38

$13.32

$24.32

52 Week Range

Now: $13.32

$7.69

$26.35

Volume

985,673 shs

Average Volume

943,410 shs

Market Capitalization

$642.56 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.42

Who are the company insiders with the largest holdings of Cabaletta Bio?: Cabaletta Bio's top insider shareholders include:
Steven Nichtberger (CEO)
Anup Marda (CFO)
Gwendolyn Binder (Insider)
Catherine Bollard (Director)
Learn More about top insider investors at Cabaletta Bio.
Who are the major institutional investors of Cabaletta Bio?: Cabaletta Bio's top institutional shareholders include:
CHURCHILL MANAGEMENT Corp — 0.10%
Learn More about top institutional investors of Cabaletta Bio stock.
Which major investors are selling Cabaletta Bio stock?: In the last quarter, CABA stock was sold by these institutional investors:
CHURCHILL MANAGEMENT Corp

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad